The term phase ii clinical trial is identified in base64 scheme by the sequence cGhhc2UgaWkgY2xpbmljYWwgdHJpYWw=, while the MD5 signature is equal to 28ef1e5ceaa4221b71e0dc4c396297e3. The ASCII encoding of phase ii clinical trial in hexadecimal notation is 706861736520696920636c696e6963616c20747269616c.